Registered entities
Epsilogen Ltd
Reg. No. 10295520United Kingdom
Innovation
9 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 273 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Social engagement
Social engagement: 3.8K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
17 investors on record; lead investors include British Patient Capital, Novartis Venture Fund, Epidarex Capital, UCL Technology Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 47% |
| Other / undisclosed | 9 | 53% |
Recent activity
22 May 2026
Event
Antibody Engineering & Therapeutics Europe conference
20 May 2026
Event
ASCO26
11 May 2026
Event
PEGSummit Boston 2026